Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosaku Nitta

Showing results (391-400 of 534) with videos related to

Pageof 54
Sort By:
Clinical and Experimental Nephrology|July 15, 2016
Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) studyDaijo Inaguma, Enyu Imai, Ayano Takeuchi, et al.
CEN Case Reports|May 17, 2017
Combined IgG4κ and IgG1λ deposition in the glomerular and tubular basement membrane accompanied by autoimmune neutropenia (AIN) and immune thrombocytopenia (ITP)Chiari Kojima, Kazuho Honda, Ari Shimizu, et al.
Clinical Transplantation|March 19, 2010
De novo membranous nephropathy and antibody-mediated rejection in transplanted kidneyKazuho Honda, Shigeru Horita, Daisuke Toki, et al.
Clinical and Experimental Nephrology|June 1, 2011
Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal functionTakahito Moriyama, Nobuyuki Amamiya, Ayami Ochi, et al.
International Urology and Nephrology|June 1, 2011
Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney diseaseTakahito Moriyama, Yuki Tsuruta, Chiari Kojima, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 30, 2016
Peritoneal Dialysis Registry With 2013 Survey ReportIkuto Masakane, Takeshi Hasegawa, Satoshi Ogata, et al.
Journal of Nephrology|October 31, 2014
High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3aTakahito Moriyama, Mitsuyo Itabashi, Takashi Takei, et al.
Clinical and Experimental Nephrology|February 15, 2022
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney diseaseTaro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Clinical and Experimental Nephrology|July 24, 2012
Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritisTakashi Takei, Mitsuyo Itabashi, Takahito Moriyama, et al.
Clinical Kidney Journal|July 5, 2021
Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patientsAngelo Karaboyas, Bruce M Robinson, Glen James, et al.
Pageof 54

Showing results (391-400 of 534) with videos related to

Sort By:
Pageof 54
Clinical and Experimental Nephrology|July 15, 2016
Risk factors for CKD progression in Japanese patients: findings from the Chronic Kidney Disease Japan Cohort (CKD-JAC) studyDaijo Inaguma, Enyu Imai, Ayano Takeuchi, et al.
CEN Case Reports|May 17, 2017
Combined IgG4κ and IgG1λ deposition in the glomerular and tubular basement membrane accompanied by autoimmune neutropenia (AIN) and immune thrombocytopenia (ITP)Chiari Kojima, Kazuho Honda, Ari Shimizu, et al.
Clinical Transplantation|March 19, 2010
De novo membranous nephropathy and antibody-mediated rejection in transplanted kidneyKazuho Honda, Shigeru Horita, Daisuke Toki, et al.
Clinical and Experimental Nephrology|June 1, 2011
Long-term beneficial effects of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy for patients with advanced immunoglobulin A nephropathy and impaired renal functionTakahito Moriyama, Nobuyuki Amamiya, Ayami Ochi, et al.
International Urology and Nephrology|June 1, 2011
Beneficial effect of aliskiren combined with olmesartan in reducing urinary protein excretion in patients with chronic kidney diseaseTakahito Moriyama, Yuki Tsuruta, Chiari Kojima, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|December 30, 2016
Peritoneal Dialysis Registry With 2013 Survey ReportIkuto Masakane, Takeshi Hasegawa, Satoshi Ogata, et al.
Journal of Nephrology|October 31, 2014
High uric acid level is a risk factor for progression of IgA nephropathy with chronic kidney disease stage G3aTakahito Moriyama, Mitsuyo Itabashi, Takashi Takei, et al.
Clinical and Experimental Nephrology|February 15, 2022
Initial decline in eGFR to predict tolvaptan response in autosomal-dominant polycystic kidney diseaseTaro Akihisa, Hiroshi Kataoka, Shiho Makabe, et al.
Clinical and Experimental Nephrology|July 24, 2012
Positive C1q staining associated with poor renal outcome in membranoproliferative glomerulonephritisTakashi Takei, Mitsuyo Itabashi, Takahito Moriyama, et al.
Clinical Kidney Journal|July 5, 2021
Hyperkalemia excursions are associated with an increased risk of mortality and hospitalizations in hemodialysis patientsAngelo Karaboyas, Bruce M Robinson, Glen James, et al.
Pageof 54